We applied the polymerase chain reaction to detection of the pathogenic protozoan Toxoplasma gondii based on our identification of a 35-fold-repetitive gene (the BI gene) as a target. Using this procedure, we were able to amplify and detect the DNA of a single organism directly from a crude cell lysate. This level of sensitivity also allowed us to detect the BI gene from purified DNA samples containing as few as 10 parasites in the presence of 100,000 human leukocytes. This is representative of the maximal cellular infiltration (105/ml) in 1 mi of cerebrospinal fluid obtained from patients with toxoplasmic encephalitis. The BJ gene is present and conserved in all six T. gondii strains tested to date, including two isolates from patients with acquired immunodeficiency syndrome. No signal was detected by using this assay and DNAs from a variety of other organisms, including several which might be found in the central nervous system of an immunocompromised host. This combination of sensitivity and specificity should make detection of the BJ gene based on polymerase chain reaction amplification a very useful method for diagnosis of toxoplasmosis both in immunocompromised hosts and in congenitally infected fetuses.
There are many instances in the diagnosis of infectious diseases in which it is desirable to detect a pathogen directly. A prominent example is the plethora of opportunistic infections of patients with acquired immunodeficiency syndrome (AIDS; 2, 42) which cannot be reliably diagnosed by serology because of severe immune system dysfunction. The polymerase chain reaction (PCR; 33) has already been used in detection of human immunodeficiency virus types 1 (17, 25, 27 ) and 2 (30) , human papillomavirus (24, 35) , human T-cell lymphoma virus (3, 11) , and cytomegalovirus (9, 34) from a variety of clinical specimens, including blood, urine, and Formalin-fixed tissue specimens, without prior extraction of DNA. In several instances, PCR has allowed direct diagnosis of viral diseases when serologic methods have failed (13, 19) . We describe below the application of PCR to detection of the pathogenic protozoan Toxoplasina gondii.
T. gondii can cause severe neurological disease or death in developing human fetuses (22) and in patients immunosuppressed as a result of drug therapy or disease (12, 15, 20) . Particularly at risk are patients with AIDS (16, 23, 26) , among whom the prevalence of toxoplasmosis is about 10% (14, 36) with the number of such afflicted persons dramatically increasing as the number of AIDS cases rises. In about 5% of AIDS cases, toxoplasmosis is the first indication of human immunodeficiency virus infection (14) .
Fetal toxoplasmosis remains a significant disease as a result of acute parasitic infection in mothers not previously infected; consequences of infection are most severe if it occurs during the first trimester. Effective prenatal diagnosis can permit a decision to terminate the pregnancy or initiate treatment of late-term fetuses in utero (8, 10) .
Current diagnosis in utero relies on a combination of detection of specific immunoglobulin M, culture of amniotic fluid and fetal blood, and other nonspecific measurements of infection (10) . The only definitive diagnosis is by culture, which takes up to 3 weeks. A more rapid method of direct detection could offer justification to start antibiotic therapy immediately.
Current diagnosis of T. gondii infection in patients with AIDS cannot rely on serology but rather relies on computerized tomography or magnetic resonance imaging scans and brain biopsies to identify parasites encysted within the brain (6, 26) . Such technology is time-consuming, expensive, and associated with considerable risk. New procedures, such as PCR, are therefore desirable for the diagnosis of toxoplasmosis both in developing fetuses and in immunocompromised hosts.
MATERIALS AND METHODS
Preparation of T. gondii cells and DNA. T. gondii C56 and independent strains Ai and A2 isolated from two patients with AIDS were grown in mouse ascites after intraperitoneal injection (strains provided by J. S. Remington, Palo Alto Medical Foundation, Palo Alto, Calif.). T. gondii RH tachyzoites were grown in a monolayer of human foreskin fibroblasts in Eagle minimal essential medium (GIBCO Laboratories) supplemented with 3% fetal bovine serum and antibiotics (28) . All strains were purified from host cell material by harvesting lysed cultures, passing the cell suspension through a 27-gauge needle, and filtering through a CF-11 cellulose (Whatman, Inc.) column (37) 7 .4)-10 mM NaCI-10 mM EDTA-10 p.g of tRNA per ml, followed by phenol-chloroform extraction and ethanol precipitation.
The B) gene. The BI gene was isolated as described elsewhere (4) . The complete sequence of the BI gene as cloned in plasmid vector pAT153 (38; to give pTXgB1) was determined by using the chemical modification method of Maxam and Gilbert (21) .
The copy number of the BI gene was determined by comparative hybridization using a titration of plasmid DNA. Serially diluted samples of pTXgB1 DNA (5, The amplification reactions were performed with the thermostable DNA polymerase of Thermuis aquaticus (Taq; Cetus Corp.) as previously described (32) . Briefly, 2.5 U of Taq polymerase was used in a 100-,ul reaction volume with 10 mM Tris (pH 8.3)-2.5 mM MgCl2-100 p.M deoxynucleoside triphosphates (Pharmacia)-each oligo at 1.0 jsM-0.01% gelatin-whole-cell lysates or purified DNA, as indicated. Samples were overlaid with 100 pi of paraffin oil (J. T. Baker Chemical Co.) in 0.6-ml tubes (Sarstedt) and amplified for 25 to 60 cycles in an automated PCR machine (Perkin-ElmerCetus, Ericomp, or a machine built in our laboratory). Each cycle consisted of 1 min of denaturation at 93°C, 1 to 2 min at the annealing temperature of 55°C, and 1.5 to 3.0 min of extension at 72°C. The final extension step continued for an additional 5 min.
Hybridization assays. Quantitation of amplified products (Fig. 3), the major surface antigen of T. gondii) and sorted directly into amplification tubes by a FACS. Samples of 0, 1, 3. 5, and 100 cells were then amplified through 60 cycles of PCR by using oligos 1 and 4 as described in Materials and Methods. For each reaction product, except the 100-cell product which had 5%W (i.e., one-sixth of the material in the other slots), 30% was denatured by formaldehyde treatment and detected by slot blot hybridization with oligo 3 as the probe. The filter also contained 65 ng of plasmid pAT153 (-) and 65 ng of pAT153 plus a 2.2-kb BI gene repeat (+) as negative and positive controls for hybridization (HYB CONT), respectively. The autoradiograph shown was exposed for 17 h.
repetitive in each isolate to allow PCR detection with roughly similar sensitivity for each.
To determine the specificity of this assay, amplification and probing using the same set of oligos were attempted with DNAs from a variety of closely related organisms, as well as those which might also be found in the central nervous system of an immunocompromised host. These included Sarcocystis, Neospora, Plasmodiurm, Aspergillus, Candida, Crytpococcus, and Absidia spp. In no case was a signal detectable (data not shown), indicating that this combination of oligos is specific for T. gondii.
Detection of amplified product from a single organism. To accurately assess the sensitivity of PCR for detection of the B! gene, we used a FACS to place 1, 3, 5, 10, and 100 T. gondii parasites directly into tubes for amplification as cell lysates. In one such experiment (Fig. 4) , 30% of the reaction products were detected by slot blot hybridization after 60 cycles of PCR amplification. The signal from a single cell was easily detected in this autoradiograph in one replicate sample (lane 2) but only barely seen in the other (lane 3) after 17 h of exposure. We attribute the weakness of the signal in lane 3 to the kinetics of amplification (any delay in amplification during the initial cycles has dramatic effects on the final level of the product). In subsequent experiments, we found detection of a single cell to be highly reproducible, both within a single amplification experiment and throughout a series of experiments (data not shown).
To more closely approximate a clinical sample of CSF or blood which would contain not only Toxoplasma cells but also human cells, we isolated human leukocytes from peripheral blood and combined them with our FACS-selected samples of T. gondii. Since we are particularly interested in the possibility of direct detection in CSF, we used levels of human cells that represent the maximum generally observed in CSF from patients with AIDS. In studies with a combined total of 42 patients, Koppel et al. (16) distilled water. With this procedure, little or no amplification was observed (data not shown). To obtain amplification in the presence of this number of cells, therefore, we tried extracting the DNA from the samples before amplification. Hence, 100,000 leukocytes were added to samples of 1, 10, 100, and 1,000 T. gondii organisms, and the DNA was extracted as described in Materials and Methods. After 55 cycles of PCR amplification, a signal from as few as 10 toxoplasma organisms was easily detected in the presence of the DNA of 100,000 human leukocytes (Fig. 5, lane 5 and less sensitive than direct amplification after cell lysis by boiling (34) . Our results confirm that some sensitivity is lost in the transition to mock clinical samples, which require extraction and contain high levels of background human DNA. However, most CSF samples contain less than 10% of the human background DNA of our mock clinical samples (16, 26, 36) . Thus, we expect that it may be possible to amplify many samples without prior extraction and with minimal preparation.
Our interest in CSF is because of anecdotal reports that tachyzoites of T. gondii are occasionally seen in pelleted material from patients with AIDS who have toxoplasma encephalitis (J. S. Remington, personal communication). However, our results also suggest that the DNA of the parasite may be directly detected in the buffy coat of peripheral blood smears, since T. gondii invades monocytes (40) and can be isolated from blood by inoculation into mice (31) . PCR amplification of the BI gene should also be applicable to the diagnosis of congenitally acquired toxoplasmosis by detection of the parasite in amniotic fluid samples. One study demonstrated that 52% of fetal infections can be identified by xenodiagnosis from amniotic fluid cells (8) . An assay based on amplification of the BI target would be faster than xenodiagnosis and offer the potential for enhanced sensitivity by detection of nonviable as well as viable parasites.
These results indicate that PCR amplification of the BI gene of T. gondii may be a viable alternative to the more time-consuming and less direct procedures currently used. Assessment of this approach in a carefully controlled analysis of clinical samples is now necessary.
